• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms.

作者信息

Giannetti Matthew P, Weller Emily, Alvarez-Twose Iván, Torrado Inés, Bonadonna Patrizia, Zanotti Roberta, Dwyer Daniel F, Foer Dinah, Akin Cem, Hartmann Karin, Rama Tiago Azenha, Sperr Wolfgang R, Valent Peter, Teodosio Cristina, Orfao Alberto, Castells Mariana

机构信息

Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.

Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.

出版信息

J Allergy Clin Immunol Pract. 2021 May;9(5):2083-2086. doi: 10.1016/j.jaip.2021.02.023. Epub 2021 Feb 23.

DOI:10.1016/j.jaip.2021.02.023
PMID:33631409
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7899934/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564c/7899934/2d3a2aac4a89/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564c/7899934/2d3a2aac4a89/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/564c/7899934/2d3a2aac4a89/gr1_lrg.jpg

相似文献

1
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms.包括肥大细胞增多症在内的肥大细胞疾病患者感染新型冠状病毒肺炎不会影响肥大细胞活化症状。
J Allergy Clin Immunol Pract. 2021 May;9(5):2083-2086. doi: 10.1016/j.jaip.2021.02.023. Epub 2021 Feb 23.
2
Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome.肥大细胞增多症和单克隆肥大细胞活化综合征患者接种新型冠状病毒疫苗的安全性
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3198-3199. doi: 10.1016/j.jaip.2021.05.010. Epub 2021 May 24.
3
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.mRNA新冠疫苗在患有皮肤和全身性肥大细胞增多症且伴有肥大细胞活化症状和过敏反应的患者中耐受性良好。
J Allergy Clin Immunol. 2021 Mar;147(3):877-878. doi: 10.1016/j.jaci.2021.01.004. Epub 2021 Jan 19.
4
Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?深入研究新冠疫苗接种引起的过敏反应：mRNA疫苗在肥大细胞疾病中是否安全？
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):193-195. doi: 10.18176/jiaci.0680. Epub 2021 Feb 12.
5
SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report.肥大细胞增多症患者的新型冠状病毒2型感染：一项EPICOVIDEHA报告
J Investig Allergol Clin Immunol. 2023 Jun 15;33(3):225-227. doi: 10.18176/jiaci.0845. Epub 2022 Jul 27.
6
New Insights into Clonal Mast Cell Disorders Including Mastocytosis.对包括肥大细胞增多症在内的克隆性肥大细胞疾病的新见解。
Immunol Allergy Clin North Am. 2018 Aug;38(3):341-350. doi: 10.1016/j.iac.2018.04.014. Epub 2018 Jun 9.
7
Gastrointestinal Involvement in Mast Cell Activation Disorders.肥大细胞活化障碍中的胃肠道受累
Immunol Allergy Clin North Am. 2018 Aug;38(3):429-441. doi: 10.1016/j.iac.2018.04.008.
8
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.COVID-19、肥大细胞、细胞因子风暴、心理压力和神经炎症。
Neuroscientist. 2020 Oct-Dec;26(5-6):402-414. doi: 10.1177/1073858420941476. Epub 2020 Jul 18.
9
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.SARS-CoV-2 激活的肥大细胞释放组织胺，增加白细胞介素-1 水平，导致 COVID-19 中的细胞因子风暴和炎症反应。
J Biol Regul Homeost Agents. 2020;34(5):1629-1632. doi: 10.23812/20-2EDIT.
10
Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.肥大细胞增多症最新进展（第二部分）：分类、预后及治疗
Actas Dermosifiliogr. 2016 Jan-Feb;107(1):15-22. doi: 10.1016/j.ad.2015.09.009. Epub 2015 Oct 30.

引用本文的文献

1
Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils.人肥大细胞、嗜碱性粒细胞和嗜酸性粒细胞中冠状病毒受体表达谱。
Cells. 2024 Jan 17;13(2):173. doi: 10.3390/cells13020173.
2
Mast cell activation may contribute to adverse health transitions in COVID-19 patients with frailty.肥大细胞活化可能导致 COVID-19 衰弱患者的健康状况恶化。
Emerg Microbes Infect. 2023 Dec;12(2):2251589. doi: 10.1080/22221751.2023.2251589.
3
Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients.肥大细胞在 COVID-19 患者严重肺部损伤发病机制中的作用。
Respir Res. 2022 Dec 21;23(1):371. doi: 10.1186/s12931-022-02284-3.
4
Incidence of symptomatic Covid-19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population.肥大细胞增多症和慢性髓性白血病患者中症状性新冠病毒感染的发生率：与奥地利普通人群的比较。
Eur J Haematol. 2023 Jan;110(1):67-76. doi: 10.1111/ejh.13875. Epub 2022 Oct 17.
5
COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.在充分的术前用药情况下，新冠病毒疫苗接种对肥大细胞疾病患者是安全的。
Vaccines (Basel). 2022 May 4;10(5):718. doi: 10.3390/vaccines10050718.
6
Mast cells in lung damage of COVID-19 autopsies: A descriptive study.新冠病毒尸检肺部损伤中的肥大细胞：一项描述性研究。
Allergy. 2022 Jul;77(7):2237-2239. doi: 10.1111/all.15293. Epub 2022 Apr 1.
7
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders.克隆性肥大细胞疾病患者的有效抗 SARS-CoV-2 免疫反应。
J Allergy Clin Immunol Pract. 2022 May;10(5):1356-1364.e2. doi: 10.1016/j.jaip.2021.12.038. Epub 2022 Jan 21.
8
Impact of mental health on disease activity in mastocytosis during COVID-19 pandemic.COVID-19 大流行期间，心理健康对肥大细胞增多症疾病活动的影响。
Allergol Int. 2022 Jan;71(1):109-116. doi: 10.1016/j.alit.2021.08.002. Epub 2021 Aug 9.
9
New Insights into the Pathogenesis of Systemic Mastocytosis.全身性肥大细胞增多症发病机制的新见解。
Int J Mol Sci. 2021 May 5;22(9):4900. doi: 10.3390/ijms22094900.
10
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM).肥大细胞增多症患者的COVID-19疫苗接种：欧洲肥大细胞增多症专家网络（ECNM）和美国肥大细胞疾病倡议组织（AIM）的建议
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2139-2144. doi: 10.1016/j.jaip.2021.03.041. Epub 2021 Apr 5.